Recent advances in treatment for Benign Prostatic Hyperplasia

Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological ad...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rij, Simon, Gilling, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754003/
https://www.ncbi.nlm.nih.gov/pubmed/26918132
http://dx.doi.org/10.12688/f1000research.7063.1
_version_ 1782415958607921152
author van Rij, Simon
Gilling, Peter
author_facet van Rij, Simon
Gilling, Peter
author_sort van Rij, Simon
collection PubMed
description Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological advances in surgical treatment are changing the way BPH is treated and are resulting in less morbidity. The future of BPH treatments is exciting, and a number of novel techniques are currently under clinical trial.
format Online
Article
Text
id pubmed-4754003
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-47540032016-02-24 Recent advances in treatment for Benign Prostatic Hyperplasia van Rij, Simon Gilling, Peter F1000Res Review Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological advances in surgical treatment are changing the way BPH is treated and are resulting in less morbidity. The future of BPH treatments is exciting, and a number of novel techniques are currently under clinical trial. F1000Research 2015-12-21 /pmc/articles/PMC4754003/ /pubmed/26918132 http://dx.doi.org/10.12688/f1000research.7063.1 Text en Copyright: © 2015 van Rij S and Gilling P http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions.
spellingShingle Review
van Rij, Simon
Gilling, Peter
Recent advances in treatment for Benign Prostatic Hyperplasia
title Recent advances in treatment for Benign Prostatic Hyperplasia
title_full Recent advances in treatment for Benign Prostatic Hyperplasia
title_fullStr Recent advances in treatment for Benign Prostatic Hyperplasia
title_full_unstemmed Recent advances in treatment for Benign Prostatic Hyperplasia
title_short Recent advances in treatment for Benign Prostatic Hyperplasia
title_sort recent advances in treatment for benign prostatic hyperplasia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754003/
https://www.ncbi.nlm.nih.gov/pubmed/26918132
http://dx.doi.org/10.12688/f1000research.7063.1
work_keys_str_mv AT vanrijsimon recentadvancesintreatmentforbenignprostatichyperplasia
AT gillingpeter recentadvancesintreatmentforbenignprostatichyperplasia

Ejemplares similares